This framework distinguishes toxicant-induced steatosis from metabolic dysfunction-associated steatotic liver disease while highlighting critical evidence gaps-particularly the absence of causal PXR validation studies and human epidemiological data. The gene discussed is NR1I2; the disease is liver disorder.